25% off all training courses Offer ends May 29, 2026
View HIPAA Courses
25% off all training courses
View HIPAA Courses
Offer ends May 29, 2026

The HIPAA Journal is the leading provider of HIPAA training, news, regulatory updates, and independent compliance advice.

Vulnerabilities Identified in Medtronic Valleylab Energy Platform and Electrosurgery Products

6 vulnerabilities have been identified in the Medtronic Valleylab energy platform and electrosurgery products, including one critical flaw that could allow an attacker to gain access to the Valleylab Energy platform and view/overwrite files and remotely execute arbitrary code.

The vulnerabilities were identified by Medtronic which reported the flaws to the Department of Homeland Security Cybersecurity and Infrastructure Security Agency under its responsible vulnerability disclosure policy.

Four vulnerabilities have been identified in the following Medtronic Valleylab products

  • Valleylab Exchange Client, Version 3.4 and below
  • Valleylab FT10 Energy Platform (VLFT10GEN) software Version 4.0.0 and below
  • Valleylab FX8 Energy Platform (VLFX8GEN) software Version 1.1.0 and below

The critical vulnerability is an improper input validation flaw in the rssh utility, which facilitates file uploads. Exploitation of the vulnerability would allow an attacker to gain administrative access to files, allowing those files to be viewed, altered, or deleted. The flaw could also allow remote execution of arbitrary code.

Get The FREE
HIPAA Compliance Checklist

Immediate Delivery of Checklist Link To Your Email Address

Please Enter Correct Email Address

Your Privacy Respected

HIPAA Journal Privacy Policy

The flaw has been assigned two CVE codes – CVE-2019-3464 and CVE-2019-3463. A CVSS v3 base score of 9.8 has been calculated for the flaws.

The products also use multiple sets of hard-coded credentials. If those credentials were discovered by an attacker, they could be used to read files on a vulnerable device. This flaw has been assigned the CVSS code – CVE-2019-13543 – and has a CVSS v3 base score of 5.4.

Vulnerable products use a descrypt algorithm for operating system password hashing. If interactive, network-based logons are disabled, combined with the other vulnerabilities, an attacker could obtain local shell access and view these hashes. The flaw – CVE-2019-13539 – has a CVSS v3 base score of 7.0.

Medtronic has released a patch for the FT10 platform, which should be applied as soon as possible. The FX8 platform will be patched in early 2020. Medtronic notes that the above products are supplied with network connections disabled by default and the Ethernet port is disabled on reboot; however, the company is aware that users often enable network connectivity.

Until the patches are applied to correct the flaws, Medtronic advises users to disconnect vulnerable products from IP networks or ensure those networks are segregated and are not accessible over the internet or via other untrusted networks.

Two further vulnerabilities have been identified in the following Medtronic Valleylab energy and electrosurgery products:

  • Valleylab FT10 Energy Platform (VLFT10GEN)
    • Version 2.1.0 and lower and Version 2.0.3 and lower
  • Valleylab LS10 Energy Platform (VLLS10GEN—not available in the United States)
    • Version 1.20.2 and lower

The FT10/LS10 Energy Platform incorporates an RFID security mechanism for authentication between the platform and instruments to prevent inauthentic instruments from being used. This security mechanism can be bypassed. The flaw has been assigned the CVE code, CVS-2019-13531, and has a CVSS v3 base score of 4.8.

The RFID security mechanism does not apply read protection, which could allow full read access to RFID security mechanism data. This flaw – CVE-2019-3535 – has a CVSS v3 base score of 4.6.

A patch has been issued to correct both of these flaws.

Author: Steve Alder is the editor-in-chief of The HIPAA Journal. Steve is responsible for editorial policy regarding the topics covered in The HIPAA Journal. He is a specialist on healthcare industry legal and regulatory affairs, and has 10 years of experience writing about HIPAA and other related legal topics. Steve has developed a deep understanding of regulatory issues surrounding the use of information technology in the healthcare industry and has written hundreds of articles on HIPAA-related topics. Steve shapes the editorial policy of The HIPAA Journal, ensuring its comprehensive coverage of critical topics. Steve Alder is considered an authority in the healthcare industry on HIPAA. The HIPAA Journal has evolved into the leading independent authority on HIPAA under Steve’s editorial leadership. Steve manages a team of writers and is responsible for the factual and legal accuracy of all content published on The HIPAA Journal. Steve holds a Bachelor’s of Science degree from the University of Liverpool. You can connect with Steve via LinkedIn or email via stevealder(at)hipaajournal.com

x

Is Your Organization HIPAA Compliant?

Find Out With Our Free HIPAA Compliance Checklist

Get Free Checklist